DK1001943T3 - Polyhydroxyalkylpyrazinderivater, deres fremstilling samt medikamenter indeholdende disse forbindelser - Google Patents

Polyhydroxyalkylpyrazinderivater, deres fremstilling samt medikamenter indeholdende disse forbindelser

Info

Publication number
DK1001943T3
DK1001943T3 DK98939679T DK98939679T DK1001943T3 DK 1001943 T3 DK1001943 T3 DK 1001943T3 DK 98939679 T DK98939679 T DK 98939679T DK 98939679 T DK98939679 T DK 98939679T DK 1001943 T3 DK1001943 T3 DK 1001943T3
Authority
DK
Denmark
Prior art keywords
substituents
chain
ch2or8
compounds
preparation
Prior art date
Application number
DK98939679T
Other languages
English (en)
Inventor
Herve Bouchard
Alain Commercon
Jean-Francois Peyronel
Corinne Terrier
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1001943T3 publication Critical patent/DK1001943T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK98939679T 1997-07-18 1998-07-15 Polyhydroxyalkylpyrazinderivater, deres fremstilling samt medikamenter indeholdende disse forbindelser DK1001943T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9709186A FR2766185B1 (fr) 1997-07-18 1997-07-18 Medicaments contenant en tant que principe actif au moins un derive substitue de polyhydroxylalkylpyrazines, les nouveaux derives polyhydroxylalkylpyrazines et leur preparation
PCT/FR1998/001545 WO1999003843A1 (fr) 1997-07-18 1998-07-15 Derives de polyhydroxyalkylpyrazines, leur preparation et medicaments les contenant

Publications (1)

Publication Number Publication Date
DK1001943T3 true DK1001943T3 (da) 2004-03-29

Family

ID=9509395

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98939679T DK1001943T3 (da) 1997-07-18 1998-07-15 Polyhydroxyalkylpyrazinderivater, deres fremstilling samt medikamenter indeholdende disse forbindelser

Country Status (12)

Country Link
US (1) US6380197B1 (da)
EP (1) EP1001943B1 (da)
JP (1) JP4443035B2 (da)
AT (1) ATE256668T1 (da)
AU (1) AU8810598A (da)
DE (1) DE69820634T2 (da)
DK (1) DK1001943T3 (da)
ES (1) ES2209186T3 (da)
FR (1) FR2766185B1 (da)
PT (1) PT1001943E (da)
WO (1) WO1999003843A1 (da)
ZA (1) ZA986330B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2788274B1 (fr) * 1999-01-11 2001-02-09 Aventis Pharma Sa Nouveaux derives de polyhydroxypyrazines, leur preparation et les compositions pharmaceutiques qui les contiennent
BRPI0718360A2 (pt) 2006-12-04 2013-11-12 Univ Illinois "composições e métodos para o tratamento do câncer com cupredoxinas e dna rico em cpg"
US8011596B2 (en) * 2008-02-13 2011-09-06 Hand Held Products, Inc. Machine readable 2D symbology printable on demand
WO2021005009A1 (en) 2019-07-05 2021-01-14 Iomx Therapeutics Ag Antibodies binding igc2 of igsf11 (vsig3) and uses thereof
EP4175668A1 (en) 2020-07-06 2023-05-10 iOmx Therapeutics AG Antibodies binding igv of igsf11 (vsig3) and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3443141B2 (ja) * 1993-10-05 2003-09-02 株式会社リコー 画像傾き検出方法及び表処理方法
FR2744365B1 (fr) 1996-02-06 1998-02-27 Inst Malgache Rech Appl Melanges isolables a partir de graines d'eugenia jambolana lamarck, leur preparation et l'utilisation de ces melanges et certains de leurs constituants comme medicaments

Also Published As

Publication number Publication date
PT1001943E (pt) 2004-07-30
DE69820634T2 (de) 2004-10-21
EP1001943A1 (fr) 2000-05-24
JP2001510187A (ja) 2001-07-31
AU8810598A (en) 1999-02-10
US6380197B1 (en) 2002-04-30
JP4443035B2 (ja) 2010-03-31
WO1999003843A1 (fr) 1999-01-28
FR2766185B1 (fr) 2001-06-15
ZA986330B (en) 1999-02-08
EP1001943B1 (fr) 2003-12-17
ES2209186T3 (es) 2004-06-16
FR2766185A1 (fr) 1999-01-22
DE69820634D1 (de) 2004-01-29
ATE256668T1 (de) 2004-01-15

Similar Documents

Publication Publication Date Title
MX9306527A (es) Bencilaminoquinuclidinas substituidas.
AU3292789A (en) Platinum(ii) complexes, their preparation and use as anti-tumour agents
FR2379553A1 (fr) Nouveaux photoinducteurs de polymerisation, compositions photopolymerisables les contenant et procede de photopolymerisation
ATE93232T1 (de) Bis(methylendioxy)biphenyl-verbindungen.
SE7706392L (sv) N-fosfonometylenmonoaminoalkanmono- och -polyfosfonsyror respektive n-fosfonometylendiaminoalkanpolyfosfonsyror samt sett for deras framstellning
DE3777583D1 (de) Ammine-n-heterocyclische platinkomplexe und antitumormittel.
DK1001943T3 (da) Polyhydroxyalkylpyrazinderivater, deres fremstilling samt medikamenter indeholdende disse forbindelser
BR9708418A (pt) Amino-e trifenil-s-triazinas hodroxissubstituídas como estabilizadores
FR2400008A1 (fr) Agents anti-hypertensifs
ES8400752A1 (es) "procedimiento para la preparacion de nuevos derivados de ciclofosfamida".
MX9101270A (es) Compuesto,preparacion y uso
NO20000198L (no) Pyrazinderivater, deres fremstilling samt medikamenter inneholdende forbindelsene
DK0410953T3 (da) Piperidinforbindelser
MA20552A1 (fr) Alkylacarboxamides de pyridylalkylamines,leurs preparations et leurs utilisations
ES2000614A6 (es) Procedimiento de obtencion de nuevos complejos de platino (ii) derivados del 2,3-dimercapto-2-butene-dinitrilato (2-)-s,s'"
DK508584A (da) Bis-(substitueret metyl)-metylisoquinolderivater og farmaceutiskepraeparater indeholdende dem
EA200001157A3 (ru) Новые замещенные производные (дигидро)бензоксазина и (дигидро)бензотиазина, способ их получения и содержащие их фармацевтические композиции
ES473733A1 (es) Procedimiento de preparacion de nuevos bis-tioaralcohil-al- cohil-alcohil-boranos
AU583267B2 (en) 9-halogen prostane derivatives
ATE129151T1 (de) Hypotriglyceridämische verwendung von bis(3,5-di- alkyl-4-hydroxyphenylthio)methanen.
ES469883A1 (es) Procedimiento para la obtencion de derivados de la hidroxi-4tiazolidinationa-2
DE69615814T2 (de) Uch-15-verbindungen
ES469955A1 (es) Un procedimiento para la preparacion de derivados de 2-naf- tilamina